Nastech Pharmaceutical Company Inc. (NSTK) Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific Advisory Board
3/27/2008 8:44:49 AM
BOTHELL, Wash.--(BUSINESS WIRE)--Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that Günter Blobel, M.D., Ph.D., has joined the Scientific Advisory Board of MDRNA, Inc., Nastech’s wholly-owned subsidiary for the development of RNAi technology and therapeutics. Dr. Blobel is a Howard Hughes Medical Institute investigator at The Rockefeller University in New York City. In 1999, Dr. Blobel was awarded the Nobel Prize in Physiology or Medicine for his work in protein research.
comments powered by